FMO5 and autoimmune disease: Its role in neutrophil activation and NADPH oxidase assembly suggests pharmacological inhibition could attenuate oxidative stress and inflammation in diabetic kidneys a strategy paralleling recent successes in targeting DAMPs in autoimmune diseases.